Literature DB >> 4036828

Effects of repeated brief coronary occlusion on regional left ventricular function and dimension in dogs.

J M Nicklas, L C Becker, B H Bulkley.   

Abstract

The cumulative effects of repeated, brief episodes of regional ischemia on myocardial function and dimension were examined in 14 open-chest dogs. The left anterior descending coronary artery was occluded for 5 minutes, followed by 10 minutes of reflow, repeated 16 times, and then 1 hour recovery. Systolic function decreased progressively in segments made repetitively ischemic and remained depressed even after 1 hour of recovery. Average systolic shortening decreased 20% from baseline after recovery from the first occlusion, 82% after the 8th, 91% after the 16th, and 104% after the 1 hour recovery (p less than 0.015, analysis of variance). End-diastolic segment length progressively increased in regions made repetitively ischemic, lengthening 4% after the first occlusion, 10% after the third occlusion, 19% after the sixteenth occlusion, and 16% after 1 hour of recovery (p less than 0.02). Nonischemic end-diastolic segment length also showed a smaller but parallel increase, while non-ischemic systolic function showed compensatory improvement. After the dogs were killed, myocardial staining with triphenyl tetrazolium chloride revealed no necrosis. Electron microscopy, performed in 5 dogs, showed scattered mitochondrial swelling in both postischemic and nonischemic regions, but no evidence of irreversible injury. The ratio of myocardial blood flow in the region made repetitively ischemic to nonischemic flow, as measured with microspheres, was 1.00 +/- 0.02 before the occlusions and 0.90 +/- 0.03 just before death (difference not significant). Thus, in the dog progressively abnormal regional systolic function and regional and global diastolic dilatation can be produced by repetitive, brief, coronary occlusions, which are not associated with histochemical or ultrastructural evidence of myocardial necrosis.

Entities:  

Mesh:

Year:  1985        PMID: 4036828     DOI: 10.1016/0002-9149(85)90889-6

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  19 in total

Review 1.  Evidence that stunning can be cumulative in man.

Authors:  C Aldo Rinaldi; Roger J C Hall
Journal:  Heart Fail Rev       Date:  2003-04       Impact factor: 4.214

Review 2.  The early and late phases of preconditioning against myocardial stunning and the essential role of oxyradicals in the late phase: an overview.

Authors:  R Bolli
Journal:  Basic Res Cardiol       Date:  1996 Jan-Feb       Impact factor: 17.165

Review 3.  Experimental evaluation of radiotracers: role of intact biological models.

Authors:  A J Sinusas
Journal:  J Nucl Cardiol       Date:  1998 Mar-Apr       Impact factor: 5.952

4.  Effect of repetitive episodes of exercise induced myocardial ischaemia on left ventricular function in patients with chronic stable angina: evidence for cumulative stunning or ischaemic preconditioning?

Authors:  C A Rinaldi; N D Masani; A Z Linka; R J Hall
Journal:  Heart       Date:  1999-04       Impact factor: 5.994

Review 5.  Positron emission tomography. Diagnostic and therapeutic implications in human myocardial ischemia.

Authors:  H R Schelbert
Journal:  Int J Card Imaging       Date:  1987

6.  Importance of wall motion analysis in the diagnosis of left main disease using stress nuclear myocardial perfusion imaging.

Authors:  Shekar P Kumar; Asssad Movahed
Journal:  Int J Cardiovasc Imaging       Date:  2003-06       Impact factor: 2.357

7.  The role of substance P in myocardial dysfunction during ischemia and reperfusion.

Authors:  H Chiao; R W Caldwell
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-03       Impact factor: 3.000

8.  Impairment of regional fatty acid uptake in relation to wall motion and thallium-201 uptake in ischaemic but viable myocardium: assessment with iodine-123-labelled beta-methyl-branched fatty acid.

Authors:  J Taki; K Nakajima; I Matsunari; H Bunko; S Takada; N Tonami
Journal:  Eur J Nucl Med       Date:  1995-12

Review 9.  Clinical relevance of myocardial "stunning".

Authors:  R Bolli; C J Hartley; R S Rabinovitz
Journal:  Cardiovasc Drugs Ther       Date:  1991-10       Impact factor: 3.727

Review 10.  Cardiovascular proteomics: past, present, and future.

Authors:  Melanie Y White; Jennifer E Van Eyk
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.